Pricing of orphan drugs in oncology and rare diseases
Objective: The objective of this paper is to determine an upper price limit for an orphan drug by taken a broader perspective and, including also other monetary and non-monetary values for the society. Methods: This model is based on the expected free cash flows and the required minimum rate of retu...
| 出版年: | Journal of Market Access & Health Policy |
|---|---|
| 主要な著者: | , |
| フォーマット: | 論文 |
| 言語: | 英語 |
| 出版事項: |
MDPI AG
2020-01-01
|
| 主題: | |
| オンライン･アクセス: | http://dx.doi.org/10.1080/20016689.2020.1838191 |